バンコマイシン耐性腸球菌フェシウム治療薬の世界市場 2020年

• 英文タイトル：Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201103712 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、バンコマイシン耐性腸球菌フェシウム治療薬の世界市場を調査対象にし、バンコマイシン耐性腸球菌フェシウム治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ダプトマイシン、リネゾリド、キヌプリスチン/ダルフォプリスチン、アンピシリン、クロラムフェニコール、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Alchemia Limited、Lytix Biopharma、Cellceutix Corporation、Alvogen、LegoChem Biosciences、Aphios Corporation、Microbiotix、Helix BioMedix、Enanta Pharmaceuticals、MGB Biopharma Limited ・メーカー別販売量、売上、市場シェア ・バンコマイシン耐性腸球菌フェシウム治療薬の地域別市場分析 ・バンコマイシン耐性腸球菌フェシウム治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・バンコマイシン耐性腸球菌フェシウム治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・バンコマイシン耐性腸球菌フェシウム治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・バンコマイシン耐性腸球菌フェシウム治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・バンコマイシン耐性腸球菌フェシウム治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・バンコマイシン耐性腸球菌フェシウム治療薬の種類別市場規模2015-2020：ダプトマイシン、リネゾリド、キヌプリスチン/ダルフォプリスチン、アンピシリン、クロラムフェニコール、その他 ・バンコマイシン耐性腸球菌フェシウム治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・バンコマイシン耐性腸球菌フェシウム治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論

Market Overview
The global Drugs for Vancomycin-Resistant Enterococcus Faecium market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Drugs for Vancomycin-Resistant Enterococcus Faecium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Drugs for Vancomycin-Resistant Enterococcus Faecium market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Drugs for Vancomycin-Resistant Enterococcus Faecium market has been segmented into
Daptomycin
Linezolid
Quinupristin/dalfopristin
Ampicillin
Chloramphenicol
Others

By Application, Drugs for Vancomycin-Resistant Enterococcus Faecium has been segmented into:
Hospital
Clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Vancomycin-Resistant Enterococcus Faecium market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Vancomycin-Resistant Enterococcus Faecium markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Vancomycin-Resistant Enterococcus Faecium market.

The report offers in-depth assessment of the growth and other aspects of the Drugs for Vancomycin-Resistant Enterococcus Faecium market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Analysis
Drugs for Vancomycin-Resistant Enterococcus Faecium competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Vancomycin-Resistant Enterococcus Faecium sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Vancomycin-Resistant Enterococcus Faecium sales, revenue and market share for each player covered in this report.

The major players covered in Drugs for Vancomycin-Resistant Enterococcus Faecium are:
Alchemia Limited
Lytix Biopharma
Cellceutix Corporation
Alvogen
LegoChem Biosciences
Aphios Corporation
Microbiotix
Helix BioMedix
Enanta Pharmaceuticals
MGB Biopharma Limited

Among other players domestic and global, Drugs for Vancomycin-Resistant Enterococcus Faecium market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Vancomycin-Resistant Enterococcus Faecium product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Vancomycin-Resistant Enterococcus Faecium, with price, sales, revenue and global market share of Drugs for Vancomycin-Resistant Enterococcus Faecium in 2018 and 2019.
Chapter 3, the Drugs for Vancomycin-Resistant Enterococcus Faecium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Vancomycin-Resistant Enterococcus Faecium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drugs for Vancomycin-Resistant Enterococcus Faecium market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drugs for Vancomycin-Resistant Enterococcus Faecium sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Daptomycin
1.2.3 Linezolid
1.2.4 Quinupristin/dalfopristin
1.2.5 Ampicillin
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market
1.4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alchemia Limited
2.1.1 Alchemia Limited Details
2.1.2 Alchemia Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alchemia Limited SWOT Analysis
2.1.4 Alchemia Limited Product and Services
2.1.5 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lytix Biopharma
2.2.1 Lytix Biopharma Details
2.2.2 Lytix Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lytix Biopharma SWOT Analysis
2.2.4 Lytix Biopharma Product and Services
2.2.5 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cellceutix Corporation
2.3.1 Cellceutix Corporation Details
2.3.2 Cellceutix Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cellceutix Corporation SWOT Analysis
2.3.4 Cellceutix Corporation Product and Services
2.3.5 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Alvogen
2.4.1 Alvogen Details
2.4.2 Alvogen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Alvogen SWOT Analysis
2.4.4 Alvogen Product and Services
2.4.5 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 LegoChem Biosciences
2.5.1 LegoChem Biosciences Details
2.5.2 LegoChem Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 LegoChem Biosciences SWOT Analysis
2.5.4 LegoChem Biosciences Product and Services
2.5.5 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aphios Corporation
2.6.1 Aphios Corporation Details
2.6.2 Aphios Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aphios Corporation SWOT Analysis
2.6.4 Aphios Corporation Product and Services
2.6.5 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Microbiotix
2.7.1 Microbiotix Details
2.7.2 Microbiotix Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Microbiotix SWOT Analysis
2.7.4 Microbiotix Product and Services
2.7.5 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Helix BioMedix
2.8.1 Helix BioMedix Details
2.8.2 Helix BioMedix Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Helix BioMedix SWOT Analysis
2.8.4 Helix BioMedix Product and Services
2.8.5 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Enanta Pharmaceuticals
2.9.1 Enanta Pharmaceuticals Details
2.9.2 Enanta Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Enanta Pharmaceuticals SWOT Analysis
2.9.4 Enanta Pharmaceuticals Product and Services
2.9.5 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 MGB Biopharma Limited
2.10.1 MGB Biopharma Limited Details
2.10.2 MGB Biopharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 MGB Biopharma Limited SWOT Analysis
2.10.4 MGB Biopharma Limited Product and Services
2.10.5 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturer Market Share in 2019
3.3.2 Top 6 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Regions (2015-2020)
4.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
4.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
4.5 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Market Share by Country
5.1.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Country (2015-2020)
5.1.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Country (2015-2020)
5.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
5.3 Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
5.4 Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Country (2015-2020)
6.2 Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
6.3 UK Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
6.4 France Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
6.5 Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
6.6 Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Regions (2015-2020)
7.2 China Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
7.3 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
7.4 Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
7.5 India Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
7.7 Australia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Market Share by Country
8.1.1 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Country (2015-2020)
8.1.2 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
8.3 Argentina Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
9.3 Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
9.4 Egypt Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
9.5 South Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Type (2015-2020)
10.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Type (2015-2020)
10.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Type (2015-2020)
11 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment by Application
11.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2015-2020)
11.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Application (2015-2020)
11.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Growth Rate (2021-2025)
12.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by Regions (2021-2025)
12.2.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025)
12.2.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025)
12.2.4 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025)
12.2.5 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025)
12.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by Type (2021-2025)
12.3.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Type (2021-2025)
12.3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Type (2021-2025)
12.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by Application (2021-2025)
12.4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Application (2021-2025)
12.4.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Vancomycin-Resistant Enterococcus Faecium by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Alchemia Limited Basic Information, Manufacturing Base and Competitors
Table 8. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 9. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 10. Alchemia Limited SWOT Analysis
Table 11. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 12. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Lytix Biopharma Basic Information, Manufacturing Base and Competitors
Table 14. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 15. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 16. Lytix Biopharma SWOT Analysis
Table 17. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 18. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Cellceutix Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 21. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 22. Cellceutix Corporation SWOT Analysis
Table 23. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 24. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Alvogen Basic Information, Manufacturing Base and Competitors
Table 26. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 27. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 28. Alvogen SWOT Analysis
Table 29. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 30. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. LegoChem Biosciences Basic Information, Manufacturing Base and Competitors
Table 32. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 33. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 34. LegoChem Biosciences SWOT Analysis
Table 35. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 36. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Aphios Corporation Basic Information, Manufacturing Base and Competitors
Table 38. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 39. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 40. Aphios Corporation SWOT Analysis
Table 41. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 42. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Microbiotix Basic Information, Manufacturing Base and Competitors
Table 44. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 45. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 46. Microbiotix SWOT Analysis
Table 47. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 48. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Helix BioMedix Basic Information, Manufacturing Base and Competitors
Table 50. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 51. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 52. Helix BioMedix SWOT Analysis
Table 53. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 54. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Enanta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 57. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 58. Enanta Pharmaceuticals SWOT Analysis
Table 59. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 60. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. MGB Biopharma Limited Basic Information, Manufacturing Base and Competitors
Table 62. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Major Business
Table 63. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Total Revenue (USD Million) (2018-2019)
Table 64. MGB Biopharma Limited SWOT Analysis
Table 65. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product and Services
Table 66. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Regions (2015-2020)
Table 71. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Countries (2015-2020)
Table 74. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries (2015-2020)
Table 76. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Countries (2015-2020)
Table 78. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Countries (2015-2020)
Table 84. South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries (2015-2020)
Table 90. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2015-2020) (K Pcs)
Table 91. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Type (2015-2020)
Table 92. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Type (2015-2020) (USD Million)
Table 93. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Type (2015-2020)
Table 94. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2015-2020) (K Pcs)
Table 95. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Application (2015-2020)
Table 96. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Regions (2021-2025)
Table 98. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Type (2021-2025)
Table 100. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Application (2021-2025)
Table 101. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Picture
Figure 2. Global Sales Market Share of Drugs for Vancomycin-Resistant Enterococcus Faecium by Type in 2019
Figure 3. Daptomycin Picture
Figure 4. Linezolid Picture
Figure 5. Quinupristin/dalfopristin Picture
Figure 6. Ampicillin Picture
Figure 7. Chloramphenicol Picture
Figure 8. Others Picture
Figure 9. Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application in 2018
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Manufacturer in 2019
Figure 34. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Regions (2015-2020)
Figure 41. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Regions in 2018
Figure 42. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
Figure 43. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
Figure 45. South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020)
Figure 47. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Countries (2015-2020)
Figure 49. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Countries in 2018
Figure 50. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries in 2018
Figure 52. United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries in 2019
Figure 58. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Regions 2019
Figure 66. China Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Countries in 2019
Figure 73. South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries in 2019
Figure 74. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel

---